BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 11519857)

  • 1. TP53 gene mutations, nuclear p53 accumulation, expression of Waf/p21, Bcl-2, and CD95 (APO-1/Fas) proteins are not prognostic factors in de novo glioblastoma multiforme.
    Kraus JA; Wenghoefer M; Glesmann N; Mohr S; Beck M; Schmidt MC; Schröder R; Berweiler U; Roggendorf W; Diete S; Dietzmann K; Heuser K; Müller B; Fimmers R; von Deimling A; Schlegel U
    J Neurooncol; 2001 May; 52(3):263-72. PubMed ID: 11519857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular analysis of the PTEN, TP53 and CDKN2A tumor suppressor genes in long-term survivors of glioblastoma multiforme.
    Kraus JA; Glesmann N; Beck M; Krex D; Klockgether T; Schackert G; Schlegel U
    J Neurooncol; 2000 Jun; 48(2):89-94. PubMed ID: 11083071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Necrogenesis and Fas/APO-1 (CD95) expression in primary (de novo) and secondary glioblastomas.
    Tohma Y; Gratas C; Van Meir EG; Desbaillets I; Tenan M; Tachibana O; Kleihues P; Ohgaki H
    J Neuropathol Exp Neurol; 1998 Mar; 57(3):239-45. PubMed ID: 9600216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival of patients with glioblastoma multiforme is not influenced by altered expression of p16, p53, EGFR, MDM2 or Bcl-2 genes.
    Newcomb EW; Cohen H; Lee SR; Bhalla SK; Bloom J; Hayes RL; Miller DC
    Brain Pathol; 1998 Oct; 8(4):655-67. PubMed ID: 9804374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of bcl-2, c-erbB-2, p53, and p21 (waf1-cip1) protein in thyroid carcinomas.
    Soda G; Antonaci A; Bosco D; Nardoni S; Melis M
    J Exp Clin Cancer Res; 1999 Sep; 18(3):363-7. PubMed ID: 10606183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
    Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
    Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of alterations affecting the p53 pathway in bladder cancer on clinical outcome, assessed by conventional and array-based methods.
    Lu ML; Wikman F; Orntoft TF; Charytonowicz E; Rabbani F; Zhang Z; Dalbagni G; Pohar KS; Yu G; Cordon-Cardo C
    Clin Cancer Res; 2002 Jan; 8(1):171-9. PubMed ID: 11801555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diversity of the apoptotic response to chemotherapy in childhood leukemia.
    Liu T; Raetz E; Moos PJ; Perkins SL; Bruggers CS; Smith F; Carroll WL
    Leukemia; 2002 Feb; 16(2):223-32. PubMed ID: 11840289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human Dkk-1, a gene encoding a Wnt antagonist, responds to DNA damage and its overexpression sensitizes brain tumor cells to apoptosis following alkylation damage of DNA.
    Shou J; Ali-Osman F; Multani AS; Pathak S; Fedi P; Srivenugopal KS
    Oncogene; 2002 Jan; 21(6):878-89. PubMed ID: 11840333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active matrix metalloproteinase 9 expression is associated with primary glioblastoma subtype.
    Choe G; Park JK; Jouben-Steele L; Kremen TJ; Liau LM; Vinters HV; Cloughesy TF; Mischel PS
    Clin Cancer Res; 2002 Sep; 8(9):2894-901. PubMed ID: 12231534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant p21 regulation in radioresistant primary glioblastoma multiforme cells bearing wild-type p53.
    Kraus A; Gross MW; Knuechel R; Münkel K; Neff F; Schlegel J
    J Neurosurg; 2000 Nov; 93(5):863-72. PubMed ID: 11059670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant p53, mdm2, and proliferation differ in glioblastomas from long-term compared with typical survivors.
    Burton EC; Lamborn KR; Forsyth P; Scott J; O'Campo J; Uyehara-Lock J; Prados M; Berger M; Passe S; Uhm J; O'Neill BP; Jenkins RB; Aldape KD
    Clin Cancer Res; 2002 Jan; 8(1):180-7. PubMed ID: 11801556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterisation of molecular alterations in microdissected archival gliomas.
    Walker C; Joyce KA; Thompson-Hehir J; Davies MP; Gibbs FE; Halliwell N; Lloyd BH; Machell Y; Roebuck MM; Salisbury J; Sibson DR; Du Plessis D; Broome J; Rossi ML
    Acta Neuropathol; 2001 Apr; 101(4):321-33. PubMed ID: 11355303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the p53/BAX pathway in colorectal cancer: low BAX is a negative prognostic factor in patients with resected liver metastases.
    Sturm I; Köhne CH; Wolff G; Petrowsky H; Hillebrand T; Hauptmann S; Lorenz M; Dörken B; Daniel PT
    J Clin Oncol; 1999 May; 17(5):1364-74. PubMed ID: 10334520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initiation of human astrocytoma by clonal evolution of cells with progressive loss of p53 functions in a patient with a 283H TP53 germ-line mutation: evidence for a precursor lesion.
    Fulci G; Ishii N; Maurici D; Gernert KM; Hainaut P; Kaur B; Van Meir EG
    Cancer Res; 2002 May; 62(10):2897-905. PubMed ID: 12019170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The intrinsic radioresistance of glioblastoma-derived cell lines is associated with a failure of p53 to induce p21(BAX) expression.
    Shu HK; Kim MM; Chen P; Furman F; Julin CM; Israel MA
    Proc Natl Acad Sci U S A; 1998 Nov; 95(24):14453-8. PubMed ID: 9826721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A role for c-myc in DNA damage-induced apoptosis in a human TP53-mutant small-cell lung cancer cell line.
    Supino R; Perego P; Gatti L; Caserini C; Leonetti C; Colantuono M; Zuco V; Carenini N; Zupi G; Zunino F
    Eur J Cancer; 2001 Nov; 37(17):2247-56. PubMed ID: 11677115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular genetic alterations in glioblastomas with oligodendroglial component.
    Kraus JA; Lamszus K; Glesmann N; Beck M; Wolter M; Sabel M; Krex D; Klockgether T; Reifenberger G; Schlegel U
    Acta Neuropathol; 2001 Apr; 101(4):311-20. PubMed ID: 11355302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of retinoblastoma gene product and p21 (WAF1/Cip 1) protein in gliomas: correlations with proliferation markers, p53 expression and survival.
    Korkolopoulou P; Kouzelis K; Christodoulou P; Papanikolaou A; Thomas-Tsagli E
    Acta Neuropathol; 1998 Jun; 95(6):617-24. PubMed ID: 9650754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of p53, p21/WAF/CIP, Bcl-2, Bax, Bcl-x, and Bak in radiation-induced apoptosis in testicular germ cell tumor lines.
    Burger H; Nooter K; Boersma AW; Kortland CJ; van den Berg AP; Stoter G
    Int J Radiat Oncol Biol Phys; 1998 May; 41(2):415-24. PubMed ID: 9607360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.